title: Inflammatory arthritis due to immune checkpoint inhibitors: challenges in diagnosis and treatment.
authors.affiliation: Division of Rheumatology, Department of Medicine, Johns Hopkins School of Medicine, 5200 Eastern Avenue, Baltimore MD, 21224, USA.
authors.forename: Laura C
authors.initials: LC
authors.lastname: Cappelli
authors.affiliation: Department of Oncology, Johns Hopkins School of Medicine,440 Eastern Avenue, Baltimore MD, 21224, USA.
authors.forename: Jarushka
authors.initials: J
authors.lastname: Naidoo
authors.affiliation: Division of Rheumatology, Department of Medicine, Johns Hopkins School of Medicine, 5200 Eastern Avenue, Baltimore MD, 21224, USA.
authors.forename: Clifton O
authors.initials: CO
authors.lastname: Bingham
authors.affiliation: Division of Rheumatology, Department of Medicine, Johns Hopkins School of Medicine, 5200 Eastern Avenue, Baltimore MD, 21224, USA.
authors.forename: Ami A
authors.initials: AA
authors.lastname: Shah
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D001168:Arthritis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D001323:Autoantibodies / Q000378:metabolism; D000069281:Autoimmune Hypophysitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D061025:Costimulatory and Inhibitory T-Cell Receptors / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D000069285:Infliximab / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications / Q000276:immunology / Q000628:therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D061025:Costimulatory and Inhibitory T-Cell Receptors; D000069285:Infliximab
keywords: cancer; immune checkpoint inhibitors; immunotherapy; inflammatory arthritis